AZD-1222/tozinameranLack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2005卷 / 1期

关键词：

D O I：

10.1007/s40278-024-57245-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：152 / 152

相关论文

共 50 条

[31] Azd-1222/immune-globulinQuadriparesis and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1923 (1) : 94 - 94
[32] Aciclovir/AZD-1222/methylprednisoloneTransverse myelitis and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1914 (1) : 19 - 19
[33] AZD-1222/immune globulinVarious toxicities and lack of efficacy: case report
[J]. Reactions Weekly, 2021, 1885 (1) : 101 - 101
[34] Azd-1222/pregabalinMultiple sclerosis relapse and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1957 (1) : 85 - 85
[35] AZD-1222/Elasomeran/TozinameranBell's palsy
[J]. Reactions Weekly, 2023, 1987 (1) : 52 - 52
[36] Azd-1222/tozinameranHeadache: 5 case reports
[J]. Reactions Weekly, 2023, 1980 (1) : 78 - 78
[37] Azd-1222/fondaparinux-sodiumThrombosis, thrombocytopenia and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1896 (1) : 77 - 77
[38] Argatroban/azd-1222/dexamethasoneThrombotic thrombocytopenia and lack of efficacy: 3 case reports
[J]. Reactions Weekly, 2021, 1875 (1) : 58 - 58
[39] Azd-1222/prednisoloneGuillain-Barre syndrome and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1898 (1) : 103 - 103
[40] AZD-1222/tozinameranMultiple sclerosis and optic neuritis
[J]. Reactions Weekly, 2024, 1996 (1) : 50 - 50

← 1 2 3 4 5 →